欢迎访问行业研究报告数据库

报告分类

重点报告推荐

当前位置:首页 > 行业导航

找到报告 33861 篇 当前为第 90 页 共 3387

所属行业:医药制造业

  • 891.全球电子皮肤贴片市场展望预测(2022-2027年)

    [医药制造业] [2023-04-28]

    Technology plays a very important role in the healthcare and medical fields. Several technological equipment and devices, such as digital thermometers, insulin pumps, smart inhaler pulse oximeters, blood glucose meters, and wireless brain sensors, have been designed for better healthcare. In the medical field, over 500,000 technological devices are being used in hospital settings and various other healthcare facilities. With growing technology in healthcare, there have been advancements in the Internet of Things (IoT) and sensors that improve patient safety, information accuracy, and critical quality control. Healthcare technology has the potential to improve the use of electronic skin patches in the medical sector.

    关键词:医疗保健;医疗领域;技术设备和装置;数字温度计;胰岛素泵;智能吸入器脉搏血氧仪
  • 892.AI赋能精准放疗 市场渗透率有望提高

    [专用设备制造业,医药制造业] [2023-04-26]

    关键词:AI;精准放疗;市场渗透率;医疗资源
  • 893.医药行业:第八批集采常态降幅,首次双非区域限价-集采专题跟踪报告

    [医药制造业] [2023-04-25]

    投资建议:国家带量采购从品种试点走向全面扩围,从原来过评且充分竞争的化药,逐步走向采购金额高、充分竞 争、社会影响强烈的全品种。我们认为国家医保控费大背景下,集采与医保谈判常态化推进,驱动行业创新,看好 能够转型升级,有望穿越“医保结界”的转型pharma和新兴biotech:恒瑞医药、百济神州、海思科、贝达药业、 和黄医药、亚盛医药、先声药业、荣昌生物、君实生物、海创药业、首药控股、盟科药业、泽璟制药、信达生物、 康方生物、我武生物、基石药业、前沿生物、康辰药业、冠昊生物、海普瑞、京新药业、恩华药业等。

    关键词:医药行业;集采;投资策略
  • 894.全球生物催化剂市场展望预测报告(2022-2027年)

    [医药制造业,化学纤维制造业] [2023-04-24]

    Biocatalysts are natural substances used for increasing the speed of chemical reactions. They include enzymes produced from biological sources. Enzymes are produced from fungi, bacteria, animals, plants, and yeast. Biocatalysts are used in different industries for a variety of purposes. The demand for global biocatalysts is increasing due to rising awareness toward health and changing government policies. As the demand for biocatalysts is increasing, companies must increase the supply of raw materials for producing enzymes in bulk. Only biobased substances are used to make enzymes; therefore, companies are engaged in extensive research & development for enzyme development.

    关键词:生物催化剂;提高化学反应速度;天然物质;酵素;生物催化剂;需求不断增加
  • 895.全球乳房植入物市场展望预测报告(2023-2028年)

    [化学纤维制造业,医药制造业] [2023-04-24]

    Breast implants are medical devices implanted under the breast tissue to enlarge breast size or replace breast tissues that have been removed due to cancer, trauma, or failure to develop symmetrically due to a severe abnormality in the breast (reconstruction). They are also used in revision surgeries, which seek to correct or improve the result of an original surgery. There are two types of breast implants approved for sale: saline-filled and silicone gel-filled. Both types have a silicone outer shell. They vary in size, shell thickness, shell surface texture, and shape (contour).

    关键词:乳房植入物;植入乳房组织;医疗设备;修复手术;生理盐水填充;硅凝胶填充
  • 896.全球生物仿制药合同制造展望预测市场(2022-2027年)

    [医药制造业] [2023-04-24]

    More than 2 billion people worldwide are not able to afford life-saving medicines, which puts their lives at risk. The rise in the development and commercialization of potentially life-saving drugs has made them more accessible and affordable. Also, the ease of accessibility to pharmaceutical drugs has minimized health inequality and enabled patients to live a better quality of life for a prolonged period. Although biologic drugs are at the forefront of therapeutic developments, their high-cost accounts for a significant portion of public and private drug expenditure worldwide. Comparatively, biosimilars are quite close in structure and function to biologic drugs and can prove to be more sustainable solutions at an affordable cost.

    关键词:药物;生活质量;生物仿制药;结构和功能
  • 897.全球生物基粘合剂市场展望预测报告(2022-2027年)

    [化学原料和化学制品制造业,医药制造业] [2023-04-24]

    In recent years, environmental regulations have focused on reducing dependence on fossil fuel materials, and the importance of developing sustainable products has generated a tremendous demand for bio-based adhesives that are based on renewable materials, such as proteins, starch, and other natural resins. In the adhesive industry, bio-based adhesives are used as binding substances. Several vendors in the packaging, construction, wood panels, and OEM industries are seeking environment-friendly adhesive products. Therefore, it is important for adhesive manufacturers to deliver products with a lower environmental impact.

    关键词:环境法规;化石燃料材料;可持续产品;生物基粘合剂;巨大需求;可再生材料;粘合剂行业
  • 898.中药行业:扶持中药从呼吁到业绩兑现,优质创新中药迎战略性机遇-二级市场投资策略报告

    [医药制造业] [2023-04-22]

    2019年以来,每年国务院都发布中医药传承相关文件;2023年2月28日,国务院办公厅日前印发《中医药振兴发展重大工程实施方案》,进一步加大“十四五”期间对中医药发展的支持力度,着力推动中医药振兴发展。《方案》明确推进中医药振兴发展的基本原则,并统筹部署了8项重点工程,包括中医药健康服务高质量发展工程、中西医协同推进工程、中医药传承创新和现代化工程、中医药特色人才培养工程(岐黄工程)等,安排了26个建设项目。其中着重提到将加速中药服务体系建设和医保支付倾斜、纳入医院考核等政策的落地,进一步加快中医药行业总体发展速度,加强供给和需求端双向建设;直接利好我国中医药企业。


    关键词:新药注册审评端;医保支付端;中医药;多项政策出台
  • 899.医药行业:培南类报价环比大幅下降,维生素B6价格上涨-原料药板块3月跟踪报告

    [医药制造业] [2023-04-22]

    价格上涨品种:大宗原料药中,维生素类:维生素B6 2月价格为127.5元/千克(环比+16.97%,同比-5.56%),烟酸价格为31元/千克(环比+6.9%,同比-38%),维生素E价格为75元/千克(环比+2.04%,同比-14.77%) ;抗生素及中间体类: 7-ACA 2月价格为450元/千克(环比+2.27%,同比-18.18%);特色原料药中;肝素:肝素2月价格为9364.72美元/千克(环比+2.56%,同比-27%) 。


    关键词:原料药;价格上涨品种;价格持平品种;价格下降品种;特色原料药
  • 900.医药生物行业:疫苗与CXO延续高景气,新冠产业链值得关注-2022年一季报前瞻

    [医药制造业] [2023-04-22]

    疫苗与医药研发外包延续高景气增长,新冠小分子药物产业链值得关注:医药研发外包(CXO)板块得益于疫情期间国内产业供应链稳定以及长期以来的“工程师红利“,预计一季度仍将保持高景气度的增长,而新冠疫苗相关公司在国内推广加强针接种的政策带动下预计相比上年一季度也将实现了业绩高增。国内已于2 月12 日应急批准了辉瑞新冠口服药Paxlovid,后者也成为国内首款获批上市的新冠口服特效药,目前国内包括君实生物、真实生物、开拓药业均已将各自在研新冠药物推进至3 期临床,后续候选药物如能获批有望持续为相关上游原料药、中间体制造企业创造收益贡献。



    关键词:医药研发外包板块;新冠小分子药物产业链;医药生物行业上市公司盈利预测
首页  上一页  ...  85  86  87  88  89  90  91  92  93  94  ...  下一页  尾页  
© 2016 武汉世讯达文化传播有限责任公司 版权所有
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服